Company Filing History:
Years Active: 2020
Title: The Innovative Mind of Piotr Garczarek in Pharmaceutical Advancements
Introduction
Piotr Garczarek, an accomplished inventor based in Nysa, Poland, has made significant contributions to the field of pharmaceuticals. With a focus on developing crystalline forms of apremilast, his work aims to enhance the delivery and efficacy of this therapeutic agent.
Latest Patents
Garczarek holds a patent for the invention titled "Crystalline forms of apremilast." This invention specifically relates to solid forms of N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]acetamide, including Form N, Form M, Form O, and Form P. The patent covers the pharmaceutical composition comprising these crystalline forms for use in treating various diseases or disorders.
Career Highlights
He is currently affiliated with Polpharma Pharmaceutical Works, a prominent company in the pharmaceutical industry. Garczarek's work has demonstrated his commitment to advancing medical treatments and improving patient outcomes through innovative pharmaceutical solutions.
Collaborations
Throughout his career, Garczarek has collaborated with talented colleagues, including Monika Oracz and Przemyslaw Skoczen. These partnerships have played a vital role in the development and refinement of his innovative pharmaceutical inventions.
Conclusion
Piotr Garczarek stands out as an influential inventor within the pharmaceutical realm, with his patented work on crystalline forms of apremilast showcasing his dedication to medical innovation. His collaborations and contributions to Polpharma not only highlight his expertise but also signify the positive impact of his inventions on healthcare.